Last reviewed · How we verify
ENN0403 20mg
At a glance
| Generic name | ENN0403 20mg |
|---|---|
| Sponsor | EnnovaBio |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ENN0403 20mg CI brief — competitive landscape report
- ENN0403 20mg updates RSS · CI watch RSS
- EnnovaBio portfolio CI